CAS 459836-30-7

PEAQX

Description:

PEAQX, with the CAS number 459836-30-7, is a synthetic compound that belongs to the class of quinoxaline derivatives. It is characterized by its unique molecular structure, which typically includes a quinoxaline core that can be modified with various functional groups to enhance its properties. PEAQX is known for its potential applications in the field of medicinal chemistry, particularly as a ligand for certain receptors or as a tool in biological research. Its solubility, stability, and reactivity can vary depending on the specific substituents attached to the quinoxaline framework. Additionally, PEAQX may exhibit interesting pharmacological activities, making it a subject of interest for further studies in drug development. As with many synthetic compounds, safety and handling precautions are essential, and its environmental impact should be assessed in accordance with regulatory guidelines. Overall, PEAQX represents a versatile compound with promising applications in various scientific fields.

Formula: C₃₄H₃₂Br₂N₆Na₄O₁₁P₂

Synonyms:

• PEAQX TETRASODIUM HYDRATE
• [[[(1S)-1-(4-BROMOPHENYL)ETHYL]AMINO](1,2,3,4-TETRAHYDRO-2,3-DIOXO-5-QUINOXALINYL)METHYL] PHOSPHONIC ACID TETRASODIUM HYDRATE
• NVP-AAM 077 tetrasodiuM hydrate
• NVP-AAM077 tetrasodiuM hydrate

[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]phosphonic acid

CAS: 459836-30-7

Formula: C₁₇H₁₇BrN₃O₅P

Purity: 98%

Color and Shape: Solid

Molecular weight: 454.2117

Ref: IN-DA003CQ7

PEAQX

CAS: 459836-30-7

PEAQX

Purity: ≥98%

Molecular weight: 454.21g/mol

Ref: 54-BUP12744

PEAQX tetrasodium hydrate

CAS: 459836-30-7

Formula: C₁₇H₁₃BrN₃Na₄O₅P·xH₂O

Molecular weight: 542.14 (anhydrous)

Ref: 7W-GL2910

PEAQX

CAS: 459836-30-7

PEAQX (NVP-AAM077) is an oral NMDA antagonist, inhibits 1A/2A receptors (IC50: 270 nM), less so 1A/2B (IC50: 29,600 nM).

Formula: C₁₇H₁₇BrN₃O₅P

Purity: 98% - 99.9%

Color and Shape: Solid

Molecular weight: 454.21

Ref: TM-T4171

PEAQX tetrasodium hydrate

CAS: 459836-30-7

PEAQX tetrasodium hydrate is a new drug for the treatment of ovarian hyperstimulation syndrome (OHSS) and endometriosis. It has been shown to be effective in reducing the symptoms of both conditions. PEAQX tetrasodium hydrate is administered by intramuscular injection. The drug acts as a constant, rather than a bolus, which helps to reduce the number of injections required and improves patient compliance. It has been shown that PEAQX tetrasodium hydrate can also be used for insemination in pediatric patients when combined with ovulation induction drugs.

Formula: C₁₇H₁₃BrN₃Na₄O₅P·xH₂O

Purity: Min. 95%

Molecular weight: 542.14 g/mol

Ref: 3D-JTA83630